| Outdoor Holding Company Announces Preferred Stock Dividend |
Globe Newswire |
05/18 |
08:00 |
| Provectus Biopharmaceuticals Reports Oral PV-10 Anti-Tumor Activity in Preclinical Bladder Cancer Study; Long-Term Survivors Show Absence of Gross Bladder Tumor at Study End |
Globe Newswire |
05/18 |
08:00 |
| Digital Realty Opens First Data Center in Barcelona, Strengthening Its Position Across the Mediterranean |
Globe Newswire |
05/18 |
08:00 |
| BIO-key Q1 Bottom-Line Improves on 34% Rise in Revenue; Expects Q2 Profitability on 65% Revenue Increase; Investor Call Today at 10am ET |
Globe Newswire |
05/18 |
07:59 |
| AP Decision Notes: What to expect in Alabama's primaries |
AP Online |
05/18 |
07:52 |
| Safe Harbor Financial Reports First Quarter 2026 Results and Provides Corporate Update |
Globe Newswire |
05/18 |
07:45 |
| FG Nexus Inc. Declares Cash Dividend on Its 8.00% Cumulative Preferred Stock, Series A |
Globe Newswire |
05/18 |
07:30 |
| Duos Technologies Reports First Quarter 2026 Results |
Globe Newswire |
05/18 |
07:30 |
| CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates |
Globe Newswire |
05/18 |
07:30 |
| NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation |
Globe Newswire |
05/18 |
07:30 |
| Zenflow Presents the BREEZE™ Pivotal Clinical Trial at the American Urological Association Annual Meeting |
Globe Newswire |
05/18 |
07:30 |
| Abaxx to Launch Silver Singapore Futures on May 22, 2026 |
Globe Newswire |
05/18 |
07:24 |
| China agrees to boost trade for US beef and poultry following Trump-Xi summit |
AP Online |
05/18 |
07:19 |
| Bitget Enters Mexico Market With SAT and UIF Registration |
Globe Newswire |
05/18 |
07:14 |
| AFX Launches Sovereign Layer 1, Providing an Optimized Execution Environment for On-chain Perp DEXes |
Globe Newswire |
05/18 |
07:05 |
| Diana Shipping Inc. Cautions of Significant Downside Risk in Genco’s Share Price |
Globe Newswire |
05/18 |
07:05 |
| SEED Therapeutics to Present Phase 1 Trial Design for ST-01156, a First-in-Human Oral RBM39 Molecular Glue Degrader, at 2026 ASCO Annual Meeting |
Globe Newswire |
05/18 |
07:00 |
| Onfolio Holdings Inc. Announces Q1 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
05/18 |
07:00 |
| Brady Corporation Reports Record Adjusted EPS in its Fiscal 2026 Third Quarter and Raises its Fiscal 2026 Adjusted EPS Guidance |
Globe Newswire |
05/18 |
07:00 |
| One Fire, Many Flames: The Immune Response Fueling Allergic and Inflammatory Diseases |
Globe Newswire |
05/18 |
07:00 |
| Ashland Board appoints Bertrand Loy as new director |
Globe Newswire |
05/18 |
07:00 |
| NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
05/18 |
07:00 |
| Design Therapeutics Announces Four-Week IV Data from the RESTORE-FA Trial of DT-216P2 Demonstrating Clinical Improvements and Comprehensive Biomarker Activity in Friedreich Ataxia |
Globe Newswire |
05/18 |
07:00 |
| Byondis Establishes Scientific Advisory Board of Recognized Leaders in Oncology Research and ADC Development |
Globe Newswire |
05/18 |
07:00 |
| BeyondSpring Announces Poster Presentation at 2026 ASCO Annual Meeting |
Globe Newswire |
05/18 |
07:00 |
